Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2172250
Max Phase: Preclinical
Molecular Formula: C14H13NO4S
Molecular Weight: 291.33
Molecule Type: Small molecule
Associated Items:
ID: ALA2172250
Max Phase: Preclinical
Molecular Formula: C14H13NO4S
Molecular Weight: 291.33
Molecule Type: Small molecule
Associated Items:
Synonyms (1): 3-(4-Methylphenylsulfonamido)Benzoic Acid
Synonyms from Alternative Forms(1):
Canonical SMILES: Cc1ccc(S(=O)(=O)Nc2cccc(C(=O)O)c2)cc1
Standard InChI: InChI=1S/C14H13NO4S/c1-10-5-7-13(8-6-10)20(18,19)15-12-4-2-3-11(9-12)14(16)17/h2-9,15H,1H3,(H,16,17)
Standard InChI Key: FEPILVGKCQHGLG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 291.33 | Molecular Weight (Monoisotopic): 291.0565 | AlogP: 2.49 | #Rotatable Bonds: 4 |
Polar Surface Area: 83.47 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.97 | CX Basic pKa: | CX LogP: 2.63 | CX LogD: -0.62 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.91 | Np Likeness Score: -1.47 |
1. Brožič P, Turk S, Adeniji AO, Konc J, Janežič D, Penning TM, Lanišnik Rižner T, Gobec S.. (2012) Selective inhibitors of aldo-keto reductases AKR1C1 and AKR1C3 discovered by virtual screening of a fragment library., 55 (17): [PMID:22881866] [10.1021/jm300841n] |
2. McCoy MA, Spicer D, Wells N, Hoogewijs K, Fiedler M, Baud MGJ.. (2022) Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale., 65 (10.0): [PMID:35581674] [10.1021/acs.jmedchem.2c00228] |
Source(1):